We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Research Breakthroughs in Imaging Biomarker Technology

By Biotechdaily staff writers
Posted on 30 Jul 2008
While currently the largest distributor of positron emission tomography (PET) radiopharmaceuticals in the United States and expanding internationally into countries and regions, such as India, the United Kingdom, Korea, and Australia, Siemens Healthcare (Erlangen, Germany) is also making progress into developing new imaging biomarkers that may be used in the future. More...


Siemens Molecular Imaging Biomarker Research facility, located in Los Angeles, CA, USA, has recently submitted an Investigational New Drug (IND) application for a new imaging agent that will help with imaging hypoxic tumors, which may be resistant to standard treatment involving chemotherapy. This type of imaging biomarker may be valuable in managing the treatment options for cancer patients.

Siemens also recently announced that the U.S. National Cancer Institute (NCI) has filed a cross-reference letter to a Type II Drug Master File that Siemens submitted to the U.S. Food and Drug Administration for its investigational 3'Deoxy-3'[18F] fluorothymidine (F-18 FLT) imaging biomarker. The cross reference allows F-18 FLT to be produced by Siemens/PETNET and used by any principle investigator in an NCI multicenter clinical trial. Moreover, the imaging biomarker will be available to independent investigators if they receive NCI approval. F-18 FLT is produced by Siemens Molecular Imaging Biomarker Research and PETNET Solutions, subsidiaries of Siemens Medical Solutions USA, Inc. The imaging biomarker has been used in studies monitoring the proliferative activity of cancer cells and it is currently being used in phase I clinical trials at several research sites.

Siemens Molecular Imaging (MI) University provides a substantive training resource for Siemens' customers. Designed to be used by the interpreting physician, referring physician, and technologist, MI University demonstrates the benefits of hybrid PET-computed tomography (CT) and single photon emission tomography- (SPECT)-CT systems, including when and how hybrid imaging influences patient management, through access to valuable clinical data and detailed case studies; video lectures; product information; and a tool for information exchange among peers

Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company is a medical solutions provider with core competence in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is a fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services.


Related Links:
Siemens Healthcare
Siemens Molecular Imaging

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
HPV Test
Allplex HPV28 Detection
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.